<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00843245</url>
  </required_header>
  <id_info>
    <org_study_id>ICREC 001-2009</org_study_id>
    <nct_id>NCT00843245</nct_id>
  </id_info>
  <brief_title>Study of Electrical Bioimpedance in Heart Failure.</brief_title>
  <acronym>BELIC</acronym>
  <official_title>Study of Electrical Bioimpedance in Heart Failure Patients Followed at the Heart Failure Unit of the Santa Creu i Sant Pau Hospital.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universitat Politècnica de Catalunya</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine how electrical impedance is modified in relation to
      extracellular space body fluid retention detected by an electrical bioimpedance method in
      patients with heart failure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Heart failure (HF) is a clinical syndrome presenting currently a high prevalence, morbidity
      and mortality. The lack of sensitivity of symptoms and signs used to make the diagnosis of
      the exacerbation of HF, and the knowledge in recent years about the relevance to detect
      congestion before consulting a specialist or go to the emergency department, support the need
      of more aggressive management of these patients.

      Bioimpedance monitoring devices for bioimpedance can provide useful data for the detection of
      congestion onset and help the decision-making in treatment.

      Because patients with heart failure suffer alterations in body composition, mainly due to the
      amount of extracellular water, the bioimpedance can objectify these variations. In heart
      failure, bioimpedance has been tested in two studies with small samples of patients
      estimating total body water. In other studies , the monitoring of intrathoracic impedance has
      been performed by measurement systems implanted in cardiac defibrillators or in cardiac
      resynchronization devices. They have proven to be useful for early detection of
      decompensation in these patients and to detect changes in impedance before the patient begins
      the clinical manifestations. Furthermore, it has been correlated the detection of
      decompensation by these devices with significant increases in NT- proBNP (diagnostic and
      prognostic marker for HF).

      The purpose of our study is to observe these changes in impedance from the patient's skin
      surface and non-invasively.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2009</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To identify if electrical bioimpedance analysis is useful for diagnosis, monitoring and prognosis in patients with heart failure.</measure>
    <time_frame>18 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To analyze segmental and whole-body bioimpedance measures in a population of heart failure patients with multi frequency body composition analysis</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To study the relation between electrical bioimpedance changes with patients' clinical situation (compensated versus decompensated HF)</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To assess potential correlations between impedance, clinical status, heart failure functional class, and NT-proBNP.</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Heart Failure</condition>
  <condition>Dyspnea</condition>
  <arm_group>
    <arm_group_label>heart failure</arm_group_label>
    <description>Heart failure attending a HF clinic with or without clinical decompensation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No intervention</description>
    <arm_group_label>heart failure</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood serum obtained from routine blood test
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients attended at the Heart Failure Unit of the Hospital de la Santa Creu i
        Sant Pau
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Outpatients &gt; 18 years of age, male or female

        Exclusion Criteria:

          -  Patients treated with renal substitutive treatment such as hemodialysis or peritoneal
             dialysis

          -  Patients with automatic implantable devices or pacemakers.

          -  Patients with metal prosthesis in right side of the body
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nuria Ribas Pizá, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nuria Ribas Pizá</last_name>
    <phone>0034932919000</phone>
    <phone_ext>1461</phone_ext>
    <email>NRIBAS@santpau.cat</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laura Astier Villaescusa</last_name>
    <phone>0034932919000</phone>
    <phone_ext>1461</phone_ext>
    <email>lastier@santpau.cat</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nuria Ribas Pizá, MD</last_name>
      <phone>34932909000</phone>
      <phone_ext>1461</phone_ext>
      <email>NRIBAS@santpau.cat</email>
    </contact>
    <contact_backup>
      <last_name>Laura Astier</last_name>
      <phone>34932909000</phone>
      <phone_ext>1461</phone_ext>
      <email>NRIBAS@santpau.cat</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Piccoli A, Rossi B, Pillon L, Bucciante G. A new method for monitoring body fluid variation by bioimpedance analysis: the RXc graph. Kidney Int. 1994 Aug;46(2):534-9.</citation>
    <PMID>7967368</PMID>
  </reference>
  <reference>
    <citation>Albert NM. Bioimpedance to prevent heart failure hospitalization. Curr Heart Fail Rep. 2006 Sep;3(3):136-42. Review.</citation>
    <PMID>16914106</PMID>
  </reference>
  <reference>
    <citation>Söderberg M, Hahn RG, Cederholm T. Bioelectric impedance analysis of acute body water changes in congestive heart failure. Scand J Clin Lab Invest. 2001 Apr;61(2):89-94.</citation>
    <PMID>11347985</PMID>
  </reference>
  <reference>
    <citation>Steele IC, Young IS, Stevenson HP, Maguire S, Livingstone MB, Rollo M, Scrimgeour C, Rennie MJ, Nicholls DP. Body composition and energy expenditure of patients with chronic cardiac failure. Eur J Clin Invest. 1998 Jan;28(1):33-40.</citation>
    <PMID>9502185</PMID>
  </reference>
  <reference>
    <citation>Yu CM, Wang L, Chau E, Chan RH, Kong SL, Tang MO, Christensen J, Stadler RW, Lau CP. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation. 2005 Aug 9;112(6):841-8. Epub 2005 Aug 1.</citation>
    <PMID>16061743</PMID>
  </reference>
  <reference>
    <citation>Lüthje L, Vollmann D, Drescher T, Schott P, Zenker D, Hasenfuss G, Unterberg C. Intrathoracic impedance monitoring to detect chronic heart failure deterioration: relationship to changes in NT-proBNP. Eur J Heart Fail. 2007 Jun-Jul;9(6-7):716-22. Epub 2007 Apr 25.</citation>
    <PMID>17462948</PMID>
  </reference>
  <reference>
    <citation>Nescolarde L, Rosell-Ferrer J, Gastelurrutia P, Bayés-Genis A, Calpe J, Hernández R. Comment on &quot;Is bioelectrical impedance vector analysis of value in the elderly with malnutrition and impaired functionality?&quot;. Nutrition. 2009 Mar;25(3):370-1; author reply 371-2. doi: 10.1016/j.nut.2008.10.009. Epub 2008 Dec 11.</citation>
    <PMID>19084379</PMID>
  </reference>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2009</study_first_submitted>
  <study_first_submitted_qc>February 12, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2009</study_first_posted>
  <last_update_submitted>June 21, 2011</last_update_submitted>
  <last_update_submitted_qc>June 21, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 22, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dr. Antoni Bayés-Genís</name_title>
    <organization>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</organization>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <keyword>Electric bioimpedance</keyword>
  <keyword>Body composition</keyword>
  <keyword>Diagnosis</keyword>
  <keyword>monitoring</keyword>
  <keyword>Prognosis</keyword>
  <keyword>Total body water</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Dyspnea</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

